These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 82976)

  • 21. [Comparative studies on the uptake and organ distribution of 57Co-bleomycin and 57Co-bleomycin-A2 in mice with squamous cell tumors of the skin and vagina].
    Pertynski T; Ketkar MB; Mariss P; Reznik G; Talas A; Dieffenbach G
    Nuklearmedizin; 1979; 18(6):300-3. PubMed ID: 94162
    [No Abstract]   [Full Text] [Related]  

  • 22. [Radioisotope diagnosis of liver neoplasms with 57Co-bleomycin, with special reference to primary liver neoplasms].
    Hasegawa Y; Nakano S; Kojima J; Kiyonaga G; Ishigami S
    Nihon Rinsho; 1975 Nov; 33(11):3286-90. PubMed ID: 54448
    [No Abstract]   [Full Text] [Related]  

  • 23. Bleomycin 111-I scanning: a new technique for detecting subclinical metastatic cancer.
    Silverstein MJ; Verma RC; Touya JJ; Bennett LR; Morton DL
    Surg Forum; 1973; 24():129-31. PubMed ID: 4142814
    [No Abstract]   [Full Text] [Related]  

  • 24. DNA interaction with 57Co-bleomycin.
    Kakinuma J; Orii H
    Nuklearmedizin; 1982 Dec; 21(6):232-5. PubMed ID: 6188112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental study of the concentration of tumor tracers in non-malignant lesions.
    De Roo MJ
    J Nucl Biol Med; 1975; 19(1):5-11. PubMed ID: 49412
    [No Abstract]   [Full Text] [Related]  

  • 26. 51Cr-bleomycin, a new oncophilic radiopharmaceutical. I. Activity concentrations in transplantable tumours and organs-tissues of mice.
    Rembelska MJ; Liniecki J
    Nuklearmedizin; 1982 Apr; 21(2):62-7. PubMed ID: 6179045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical evaluation of radio-labelled bleomycin for tumor detection.
    Rasker JJ; Beekhuis H; van de Poll MA; Versluis A; Jurjens H; Woldring MG
    Nuklearmedizin; 1978 Dec; 17(6):238-48. PubMed ID: 84374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tumorscanning of head and neck with 57Co-bleomycine (author's transl)].
    Jung H; Gamm H; Wolf R; Fischer J
    Radiologe; 1974 Nov; 14(11):513-6. PubMed ID: 4141110
    [No Abstract]   [Full Text] [Related]  

  • 29. [Tumor affinity and DNA interactions of 57Co-bleomycin (author's transl)].
    Kakinuma J; Honjo Y; Orii H
    Radioisotopes; 1982 Apr; 31(4):175-8. PubMed ID: 6180460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of 131-I-CEA antibody as a tumor scanning agent.
    Hoffer PB; Lathrop K; Bekerman C; Fang VS; Refetoff S
    J Nucl Med; 1974 May; 15(5):323-7. PubMed ID: 4132666
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of carcinoma of the cervix using 111In-bleomycin.
    Woolfenden JM; Waxman AD; Disaia PJ; Siemsen JK
    Obstet Gynecol; 1975 Sep; 46(3):347-52. PubMed ID: 51490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracellular distribution of 57Co-bleomycin.
    Konings AW; Rasker JJ; Posthuma GA
    Curr Top Radiat Res Q; 1978 Jan; 12(1-4):497-512. PubMed ID: 76527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of I-bleomycin prepared by two methods stability and pharmacokinetics in tumor-bearing mice.
    Krohn KA; Meyers J; DeNardo GL
    Radiology; 1977 Jan; 122(1):179-82. PubMed ID: 63131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 57Co-hematoporphyrin accumulation by experimental tumors.
    Anghileri LJ; Heidbreder M; Mathes R
    Nuklearmedizin; 1976 Aug; 15(4):183-4. PubMed ID: 980796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new tumor imaging agent--111In-bleomycin complex. Comparison with 67Ga-citrate and 57Co-bleomycin in tumor-bearing animals.
    Hou DY; Hoch H; Johnston GS; Tsou KC; Jones AE; Miller EE; Larson SM
    J Surg Oncol; 1984 Nov; 27(3):189-95. PubMed ID: 6208427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cobalt-labeled bleomycin--a new radiopharmaceutical for tumor localization. A comparative clinical evaluation with gallium citrate.
    Poulose KP; Watkins AE; Reba RC; Eckelman WC; Goodyear M
    J Nucl Med; 1975 Sep; 16(9):839-41. PubMed ID: 51080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability of 111In-bleomycin in vivo--properties compared with 57Co-bleomycin.
    Hou DY; Hoch H; Johnston GS; Tsou KC; Farkas RJ; Miller EE
    Eur J Nucl Med; 1983; 8(12):535-40. PubMed ID: 6199207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Some experience with 57Co-labeled bleomycin as a tumor-seeking agent.
    Rasker JJ; Poll AM; Beekhuis H; Woldring MG; Nieweg HO
    J Nucl Med; 1975 Nov; 16(11):1058-69. PubMed ID: 52700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influence of radiotherapy upon tumor accumulation and organ distribution of 57Co-bleomycin in mice with chemically induced squamous cell carcinoma (author's transl)].
    Pertynski T; Ketkar MB; Mariss P; Reznik G; Hassenstein E; Nüsslin F; Dieffenbach G; Haindl H
    Strahlentherapie; 1979 Nov; 155(11):770-3. PubMed ID: 92831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of indium-111 BLEDTA in man.
    Sartoris DJ; Goodwin DA; Meares CF; DeRiemer LH; Fajardo LF
    Invest Radiol; 1984; 19(3):221-7. PubMed ID: 6206021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.